Clinical Trials in Austria

• A Randomized, Placebo-controlled, Double-blind, Parallel group, 6 Month Study to Evaluate the Safety, Tolerability, and Potential Efficacy o… Not authorised
  2022-500828-30-00 Phase II Early Alzheimer´s Disease Cyclo Therapeutics Inc.
• A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of k… Not authorised
  2022-501389-23-00 Phase II end-stage renal disease or otherwise an insufficient kidney … Corline Biomedical AB
• Clinical trial of MK-7648A in adults and children with skin cancer Not authorised
  2022-501417-31-00 Phase III High-risk Resected Melanoma Merck Sharp & Dohme LLC
• An early access study of ivosidenib in patients with a pretreated locally advanced or metastatic cholangiocarcinoma Not authorised
  2022-501463-40-00 Phase III Locally Advanced or Metastatic Cholangiocarcinoma Servier Affaires Medicales
• Phase 3 Study Assessing Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Orbit) Not authorised
  2022-501535-16-00 Phase III Atopic Dermatitis (AD) Amgen Inc.
• A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major d… Not authorised
  2022-502185-24-00 Phase III Schizophrenia, schizoaffective disorder, schizophreniform di… University Medical Center Utrecht
• Psilocybin's effects on anhedonia Not authorised
  2023-509009-59-00 Phase I (Other) Major Depressive Disorder Medical University of Vienna
• A phase 2 study to research the safety and efficacy of datopotamab deruxtecan for non-squamous non-small cell lung cancer patients with acti… Not authorised
  2024-512369-14-00 Phase II Non-small cell lung cancer (NSCLC). Medica Scientia Innovation Research S.L.
• A one-year study to assess if Xanomeline/Trospium (XT) can improve cognitive function in adults living with schizophrenia. Not authorised
  2025-523060-20-00 Phase III Schizophrenia European Group for Research in Schizophrenia Stichting
• A Clinical Trial of OM336 to Help Immunized Patients Become Eligible for Kidney Transplantation Not authorised
  2025-523222-40-00 Phase II End stage renal failure Medical University Of Vienna
• IMPD-Q-only application Not authorised
  2025-524730-26-00 Phase I (Other) prick test-induced itch Incyte Corp.
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown
  2022-502779-40-99 Phase III Primary prevention of atherosclerotic cardiovascular disease… Novartis Pharma AG
• A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown
  2025-523766-25-00 Phase III Ulcerative colitis Merck Sharp & Dohme LLC
• Stroke in childhood due to inflammatory narrowing of blood vessels: Treatment with steroids Pending
  2022-500631-36-00 Phase III Focal cerebral arteriopathy and childhood stroke Focal cereb… Insel Gruppe AG
• A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of k… Pending
  2022-501389-23-02 Phase II end-stage renal disease or otherwise an insufficient kidney … Corline Biomedical AB
• Randomised efficacy and safety clinical trial of PQ Birch in subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by … Pending
  2023-507427-28-00 Phase III seasonal allergic rhinitis and/or rhinoconjunctivitis Allergy Therapeutics (UK) Limited
• A research study on how well cagrilintide and CagriSema work in children and adolescents with excess body weight Pending
  2023-509176-42-00 Phase III/IV Obesity and T2D Novo Nordisk A/S
• IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending
  2023-509392-17-00 Phase III Relapsed Acute Lymphoblastic Leukemia (ALL) Charite Universitaetsmedizin Berlin KöR
• A Study of Anti-CD19 CAR T-cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis Pending
  2024-511168-10-00 Phase II Primary or Secondary Progressive Multiple Sclerosis Kyverna Therapeutics Inc.
• Prospective analysis of the therapeutic efficacy of iron isomaltoside in combination with or without dopaminergic therapy in patients with r… Pending
  2024-512117-40-00 Phase III restless leg syndrome Medizinische Universitaet Innsbruck
• A randomized, placebo-controlled, double-blind, single-ascending-dose, Phase 1a/b study to assess the safety, pharmacokinetics, pharmacodyna… Pending
  2024-512196-12-00 Phase I Acute Ischemic Stroke Neutrolis Inc.
• A prospective, open-label, randomized, multicenter phase-III trial to evaluate the efficacy of pirtobrutinib and epcoritamab compared with R… Pending
  2024-513445-37-00 Phase III previously untreated RT, irrespective of risk factors and di… University Of Cologne
• SIOP PNET 5 medulloblastoma Pending
  2024-513724-42-00 Phase II/III Medulloblastoma University Medical Center Hamburg-Eppendorf
• Daratumumab in Combination with Carfilzomib, Pomalidomide and Dexamethasone in patients with myeloma induced acute renal failure Pending
  2024-514702-31-00 Phase II Multiple myeloma Medizinische Universitaet Innsbruck

Showing 1–24 of 1,100 trials